Last reviewed · How we verify
NCT06250790
Selective Coronary Revascularization in Peripheral Artery Disease Patients (SCOREPAD Trial)
trial testing Coronary CT angiography and FFRct analysis in Peripheral Arterial Disease in 600 participants. Currently enrolling.
15 February 2026
Quick facts
| Lead sponsor | Pauls Stradins Clinical University Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 15 February 2024 |
| Primary completion | 15 February 2026 |
| Estimated completion | 15 February 2029 |
| Sites | 1 location across Latvia |
Drugs / interventions tested
- Coronary CT angiography and FFRct analysis
Conditions studied
- Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Pauls Stradins Clinical University Hospital
Who can join
50 and older, any sex, with Peripheral Arterial Disease or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to determine whether among symptomatic Peripheral Arterial Disease (PAD) patients with no known Coronary Artery Disease (CAD) who had undergone lower-extremity revascularization, a strategy of best medical therapy (BMT) plus selective coronary revascularization based on FFRct assessment of lesion-specific coronary ischemia can reduce adverse cardiac events and improve survival compared to BMT alone. Lesion-specific coronary ischemia is defined as FFRCT ≤0.80 distal to stenosis in a major (≥2 mm) coronary artery with severe ischemia defined as FFRCT ≤0.75.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Contemporary Functional Coronary Angiography: An Update.
Bennett J, Chandrasekhar S, Woods E, McLean P, et al · · 2024 · cited 1× · PMID 39445463 · DOI 10.1080/14796678.2024.2416817
Verify or expand the search:
- PubMed search for NCT06250790
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Coronary CT angiography and FFRct analysis
Trials testing the same drug.
- NCT06546761 — Selective Coronary Revascularization in Carotid Artery Disease Patients After Carotid Revascularization (SCORECAD Trial) · recruiting
Other recruiting trials for Peripheral Arterial Disease
Currently open trials in the same condition.
- NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
- NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
- NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
- NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
- NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting
Other Pauls Stradins Clinical University Hospital trials
Trials by the same sponsor.
- NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
- NCT06846138 — Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study · NA · enrolling by invitation
- NCT06546761 — Selective Coronary Revascularization in Carotid Artery Disease Patients After Carotid Revascularization (SCORECAD Trial) · recruiting
- NCT06090149 — Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients · NA · unknown
- NCT06681415 — Efficacy of 20% Human Albumin in Reducing Pleural Effusion After Cardiopulmonary Bypass · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06250790 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pauls Stradins Clinical University Hospital
- Last refreshed: 16 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06250790.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing